Emerging Science
Can pharma overcome obesity?
Ozempic, Wegovy, and Mounjaro are part of a new class of semaglutides (GLP-1 receptor agonists) that help treat obesity and diabetes by regulating blood sugar and appetite.
Read the CAS Insights article
Bio
Terra Williams is a content scientist with a B.S. in Biological Engineering, and a minor in Biomedical Engineering from The Ohio State University. Before joining CAS, she gained industry experience in both toxicology and biomaterials at Victoria's Secret & Co.